Percutaneous treatment in mitral valve regurgitation

Paolo Denti; Alfieri Ottavio

doi:10.1007/9781447164883_17

Percutaneous treatment in mitral valve regurgitation

Paolo Denti, Alfieri Ottavio

IRCCS Ospedale San Raffaele

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

Percutaneous mitral valve intervention (PMVI) has become an alternative therapeutic option for patients who are not eligible for conventional surgical treatment of mitral regurgitation (MR). PMVI can correct MR by means of the direct or indirect reduction of mitral annular dilatation, or through intervention on the primary or secondary abnormalities of the mitral apparatus. Among PMVI techniques, the MitraClip system, which is able to reproduce the edge-to-edge surgical procedure, is the only percutaneous therapeutic approach that can presently be considered clinically validated.

Original language	English
Title of host publication	Secondary Mitral Valve Regurgitation
Publisher	Springer-Verlag London Ltd
Pages	153-164
Number of pages	12
ISBN (Print)	9781447164883, 9781447164876
DOIs	https://doi.org/10.1007/9781447164883_17
Publication status	Published - Jan 1 2015

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1007/9781447164883_17

Fingerprint Dive into the research topics of 'Percutaneous treatment in mitral valve regurgitation'. Together they form a unique fingerprint.

Cite this

@inbook{fbddedc96cc3470cb426407b89601a6e,

title = "Percutaneous treatment in mitral valve regurgitation",

abstract = "Percutaneous mitral valve intervention (PMVI) has become an alternative therapeutic option for patients who are not eligible for conventional surgical treatment of mitral regurgitation (MR). PMVI can correct MR by means of the direct or indirect reduction of mitral annular dilatation, or through intervention on the primary or secondary abnormalities of the mitral apparatus. Among PMVI techniques, the MitraClip system, which is able to reproduce the edge-to-edge surgical procedure, is the only percutaneous therapeutic approach that can presently be considered clinically validated.",

author = "Paolo Denti and Alfieri Ottavio",

year = "2015",

month = jan,

day = "1",

doi = "10.1007/9781447164883_17",

language = "English",

isbn = "9781447164883",

pages = "153--164",

booktitle = "Secondary Mitral Valve Regurgitation",

publisher = "Springer-Verlag London Ltd",

}

TY - CHAP

T1 - Percutaneous treatment in mitral valve regurgitation

AU - Denti, Paolo

AU - Ottavio, Alfieri

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Percutaneous mitral valve intervention (PMVI) has become an alternative therapeutic option for patients who are not eligible for conventional surgical treatment of mitral regurgitation (MR). PMVI can correct MR by means of the direct or indirect reduction of mitral annular dilatation, or through intervention on the primary or secondary abnormalities of the mitral apparatus. Among PMVI techniques, the MitraClip system, which is able to reproduce the edge-to-edge surgical procedure, is the only percutaneous therapeutic approach that can presently be considered clinically validated.

AB - Percutaneous mitral valve intervention (PMVI) has become an alternative therapeutic option for patients who are not eligible for conventional surgical treatment of mitral regurgitation (MR). PMVI can correct MR by means of the direct or indirect reduction of mitral annular dilatation, or through intervention on the primary or secondary abnormalities of the mitral apparatus. Among PMVI techniques, the MitraClip system, which is able to reproduce the edge-to-edge surgical procedure, is the only percutaneous therapeutic approach that can presently be considered clinically validated.

UR - http://www.scopus.com/inward/record.url?scp=84955346116&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84955346116&partnerID=8YFLogxK

U2 - 10.1007/9781447164883_17

DO - 10.1007/9781447164883_17

M3 - Chapter

AN - SCOPUS:84955346116

SN - 9781447164883

SN - 9781447164876

SP - 153

EP - 164

BT - Secondary Mitral Valve Regurgitation

PB - Springer-Verlag London Ltd

ER -

Percutaneous treatment in mitral valve regurgitation

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this